Riskpilot← Back to searchSign inGet full accessNjord International AB
ABActiveOrg 5591986830Medicinaregatan 8 BWholesale of pharmaceutical and medical goods · NACE 4646Est. 201910-19 employees
Revenue 2024
SEK 5,7M
+38% vs 2023
EBITDA margin
-154.9%
-46% vs 2023
Equity ratio
89.0%
Financial strength
Net profit 2024
SEK -10,1M
-35% vs 2023
| Revenue | SEK 5,7M | +38% |
| EBITDA | SEK -8,9M | -46% |
| Net profit | SEK -10,1M | -35% |
| Total assets | SEK 18,9M | +44% |
| Equity | SEK 16,8M | +49% |
| Employees | — | — |
Legal name
Njord International AB
Org number
5591986830
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13 mars 2019
Share capital
SEK 111 540
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall på kommersiella grunder bedriva utveckling, tillverkning och försäljning av kvalificerade produkter och tjänster inom området medicinteknik, ävensom idka därmed förenlig verksamhet.
Address
Medicinaregatan 8 B
Email
gunborg@njordmedtech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 551 | 4 170 | 5 748 |
| Staff expenses | — | — | — | — | −5 580 |
| EBITDA | 168 | 80 | −873 | −6 102 | −8 903 |
| Depreciation & amort. | −156 | −0 | −0 | −1 367 | −1 367 |
| EBIT | 12 | 80 | −873 | −7 469 | −10 270 |
| Net financials | — | −126 | −51 | −1 | 157 |
| Profit before tax | 12 | −46 | −924 | −7 471 | — |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | 12 | −46 | −924 | −7 471 | −10 113 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 867 | 5 573 | 10 884 | 13 155 | 18 916 |
| Equity | 122 | 3 863 | 9 433 | 11 290 | 16 832 |
| Long-term debt | 682 | 1 087 | 869 | 855 | 195 |
| Short-term debt | 63 | 623 | 583 | 1 010 | 1 889 |
| Total debt | 745 | 1 710 | 1 452 | 1 865 | 2 084 |
EBITDA margin
-154.9%
This company
15.8%
Market median
-1080% vs market
20202024
Equity ratio
89.0%
This company
38.2%
Market median
+133% vs market
20202024
Return on equity
-60.1%
This company
18.4%
Market median
-427% vs market
20202024
Net profit margin
-176.0%
This company
8.1%
Market median
-2273% vs market
20202024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20202024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BJ Audit | Audit | 2021 |
JO Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2021 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2024 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Njord International AB (this company)
NJORD MEDTECH LTDNjord Medtech LtdBoard members of Njord International AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Jonas Jonasson | Audit | 0 companies |
| Jacob Olof Ahrnstein | Chief Executive Officer | 0 companies |
| Barbro Christina Cagner | Board of Directors | 0 companies |
| Jan Erik Gustav Smith | Board of Directors | 0 companies |
| Louise Anna Warme | Board of Directors | 0 companies |
| Amanda Lantz | Deputy Board Member | 0 companies |
| Joakim Gunnar Axel Bergman | Board of Directors | 0 companies |
| Karl Mattias Guldstrand | Chairman | 0 companies |
| Ulf Ragnar Severin | Board of Directors | 0 companies |
| Rom Hillel Mendel | Board of Directors | 0 companies |
| Marcus Emanuel Bredberg | Board of Directors | 0 companies |
| Daniel Hill | Board of Directors | 0 companies |